marked.bio: IDH1/2 mutationhttps://marked.bio/biomarker/idh12-mut/index.html Weekly changes in IDH1/2 mutation trials and approvals.en IDH1/2 mutation, week to 27 October 2026: 1 new trialhttps://marked.bio/biomarker/idh12-mut/index.html#whats-newmarked.bio-idh12_mut-2026-10-27Tue, 27 Oct 2026 12:00:00 +0000<p><b>1 new trial</b> on marked.bio between 20 October 2026 and 27 October 2026.</p><h3>New trials (1)</h3><ul><li><a href="https://clinicaltrials.gov/study/NCT07888647">IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas</a> (Phase 2, German Cancer Research Center) <i>IDH1/2 mutation</i></li></ul>